======= AASDH ======= == Gene Information == * **Official Symbol**: AASDH * **Official Name**: aminoadipate-semialdehyde dehydrogenase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=132949|132949]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q4L235|Q4L235]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AASDH&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AASDH|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614365|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the non-ribosome peptide syntesase (NRPS) enzyme family. The encoded protein contains an AMP-binding domain, PP-binding (phosphopantetheine, or pantetheine 4'phosphate-binding) domain and the Pyrrolo-quinoline quinon (PQQ) binding domain. The protein is expressed in several adult tissues. [provided by RefSeq, Apr 2016]. * **UniProt Summary**: N/A |AMP-binding| |PP-binding| |amino acid activation for nonribosomal peptide biosynthetic process| |acid-thiol ligase activity| |beta-alanine metabolic process| |nonribosomal peptide biosynthetic process| |amino acid activation| |neurotransmitter metabolic process| |cellular amino acid metabolic process| |fatty acid metabolic process| |regulation of neurotransmitter levels| |peptide biosynthetic process| |amide biosynthetic process| |peptide metabolic process| |monocarboxylic acid metabolic process| |cellular amide metabolic process| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |organonitrogen compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-1.91| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|1.71| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.74| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.75| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.76| |[[:results:exp493|IL-3 9ng/ml R08 exp493]]|1.77| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.82| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|1.83| |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|1.83| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|1.86| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.86| |[[:results:exp360|Genistein 15μM R07 exp360]]|1.88| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|1.89| |[[:results:exp425|Beta-Estradiol 0.55μM R07 exp425]]|2.02| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16643 * **Expression level (log2 read counts)**: 4.37 {{:chemogenomics:nalm6 dist.png?nolink |}}